Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
about
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingRNAi and RNAa--the yin and yang of RNAomeNanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the artSmart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapyGold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.Inner ear drug delivery for auditory applications.Targeted suppression of HO-2 gene expression impairs the innate anti-inflammatory and repair responses of the cornea to injury.Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.Non-condensing polymeric nanoparticles for targeted gene and siRNA deliveryNanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism.Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivoDistinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia.Decreases in Casz1 mRNA by an siRNA Complex Do not Alter Blood Pressure in MiceNeutral polymeric micelles for RNA deliveryLactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma.Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells.Polycation-based nanoparticle delivery for improved RNA interference therapeutics.Nonviral delivery of synthetic siRNAs in vivo.Tracking in vitro and in vivo siRNA electrotransfer in tumor cells.Nonviral methods for siRNA deliveryLipid-based systemic delivery of siRNA.Engineering RNA for targeted siRNA delivery and medical application.Novel applications for glycosylphosphatidylinositol-anchored proteins in pharmaceutical and industrial biotechnology.Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.Engineered nanostructural materials for application in cancer biology and medicine.Biogenic amines and the control of neuromuscular signaling in schistosomes.Therapeutic siRNA: principles, challenges, and strategies.siRNA: a new approach to target neuropathic pain.Nanotechnology to drive stem cell commitment.Antibody-mediated delivery of therapeutics for cancer therapy.Recent developments in nanomedicine for melanoma treatment.Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs.Multicompartment micelle-structured peptide nanoparticles: a new biocompatible gene- and drug-delivery tool.Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacyEfficient nanoparticle mediated sustained RNA interference in human primary endothelial cells.Effects of Lipofectamine 2000/siRNA complexes on autophagy in hepatoma cells.Targeting transforming growth factor βRII expression inhibits the activation of hepatic stellate cells and reduces collagen synthesis.Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models.
P2860
Q21223671-486764AB-BEB9-4F1C-852F-18A0C8E6B66CQ24642007-B80F771C-6F2E-4DED-99CF-0770BF7A0D18Q26751229-DC0F5561-FF02-4C54-95CE-18A4413BD50CQ27025832-1462617A-513F-4D2C-B1D3-60F81736B67FQ30389591-4FF1E465-73E6-48BA-A083-41569A963629Q30484636-268E8C4F-6C4F-4AA9-A643-F121319F30AAQ33892448-997313F1-D1EA-4C9E-9444-CCB0658A8558Q34233801-3BD52F2D-DD2C-4425-B59E-F49FFFA1F0E4Q34791651-318B430D-B51F-405D-9074-C091456449D4Q35190149-35D45003-38DF-479B-B9E3-BBBC145A045CQ35439618-E5DDDB91-4A64-423E-ADE5-B880F1F97305Q35875509-BDEB9202-311D-46B3-AD7C-CA5EB6EBA82DQ35928855-659DFED6-C6D3-4D4E-8964-7CA89E237FBAQ36330524-B89C0945-9CDD-48EB-9E4A-DFE5BCA6D974Q36763827-5D7D0202-F9A7-4405-B871-866C5ADDDD0EQ36901850-2109FA8F-7BAB-4094-848F-C48B3F64FFA2Q36918516-27C2F884-4E76-4EAD-AE77-0BC48296ACB1Q36919830-469A2A3C-FBCE-4E00-99A3-C3D34335358DQ37012046-0BC3C26B-4293-4B17-8821-6D7526CE7D55Q37024768-AB1946B8-7FCE-4D33-994B-C3248527D4C8Q37331691-C1227F54-7B8C-452F-9EB4-ABB82A2DB8FCQ37360226-D9AEB345-8295-4FE2-ADE0-BDC244EFD23AQ37425606-9D498820-4A8B-434D-99A2-BDF5AC459BF9Q37709610-32514F70-85A2-4131-81A0-E02CC3B27220Q37854052-BE799A1F-FA98-4B82-8CB3-BFAC63A79663Q37922198-D2C8FD04-C2E5-47F1-B356-2DAE5024788EQ37924697-E9F1A4EE-ED83-44CA-9835-1E86712AA862Q38004814-35EBA3BD-45D8-4785-AF0E-5E261F027392Q38021996-AF3AF137-3741-41DE-BA49-DC6FA8A23704Q38051429-90F1633E-EFD0-43BA-A04C-8FAB3AD8F1BAQ38087987-41D3590E-4649-4DDC-8031-D3830C0A7FAEQ38665425-F7AC2B2B-1576-430A-9E8A-1DC2610576C5Q38740124-F01A4C4B-B8C9-4B72-9C35-B1A0859A52C9Q38889289-E7449EE4-B091-46E0-9FCF-EB2B93D365BFQ39156733-93832C6F-428A-4535-BEBF-4095CDB40E9AQ39428098-B73DABDD-B5CD-49C4-B0FD-7C1C66D35D87Q39459692-255F3721-9BA2-440A-8B02-5448C2F17D81Q39527202-188FF115-8729-48E2-8878-4D4D398C2AF2Q39580698-8EB3DB7E-CD50-4134-92C7-06C162429956Q39751683-2A9C649B-B657-463B-AEDD-C374EE7B9BAB
P2860
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@ast
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@en
type
label
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@ast
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@en
prefLabel
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@ast
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@en
P2093
P1433
P1476
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.
@en
P2093
Frank Y Xie
Martin C Woodle
Patrick Y Lu
P356
10.1016/S1359-6446(05)03668-8
P577
2006-01-01T00:00:00Z